Posting of Notice of AGM

Benchmark Holdings PLC
09 January 2024
 

9 January 2024

Benchmark Holdings plc

("Benchmark" or "the Company")

Posting of Notice of AGM

Benchmark (AIM: BMK), the aquaculture health, nutrition and genetics business, announces that further to the announcement made on 7 December 2023, notice of the 2024 Annual General Meeting ("AGM") and related form of proxy have been posted to shareholders today.

The AGM will be held on 8 February 2024 at 12.00 midday (UK time) at the offices of Travers Smith LLP, 10 Snow Hill, London, EC1A 2AL.

A copy of the AGM notice and an accompanying form of proxy have also been sent to those beneficial holders whose ordinary shares are registered in the name of Euroclear Nominees as custodian for DNB Bank ASA ("DNB") and are held by DNB as nominee in The Norwegian Central Securities Depository (Euronext Securities Oslo) ("ESO shareholders"). Details of how ESO shareholders can ensure their vote is cast at the AGM are set out in the AGM notice and the accompanying form of proxy for ESO shareholders.

The Board is keen to encourage engagement with shareholders. In order to facilitate this, if you are unable to attend but would like to ask the Board a question on the business of the AGM, please submit your questions by email to AGM@bmkholdings.com, so as to arrive by 12.00 midday (UK time) on 1 February 2024. Responses will be made via return email or published on our investor website at www.benchmarkplc.com/investors/, as deemed appropriate by the Board of Directors.

 Enquiries

Benchmark Holdings plc

Tel:  0114 240 9939

 

Trond Williksen, CEO

 

 

Septima Maguire, CFO

 

 

Ivonne Cantu, Investor Relations

 

 


 

 

Deutsche Numis (Nominated Adviser and Broker)

Tel: 020 7260 1000

 

Freddie Barnfield, Duncan Monteith, Sher Shah

 

 

 


 

MHP

 

 

Katie Hunt, Reg Hoare

Tel: 020 3128 8004

benchmark@mhpgroup.com

 



 

Equity Development

Tel:  020 7065 2692

 

Hannah Crowe


 


 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings